Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia

Glucocorticoids (GC) replacement are the mainstay treatment for 21-hydroxylase deficiency (21-OHD), the most common cause of congenital adrenal hyperplasia (CAH), in its classical form. There are novel insights into the genetic basis of the GC action diversity that point to an important role for GC...

Descripción completa

Detalles Bibliográficos
Autores principales: Botelho Barra, Cristina, Villela, Thais Ramos, Soares, Nedstâni de Freitas, Colosimo, Enrico Antônio, Belisário, André Rolim, e Silva, Ana Cristina Simões, Silva, Ivani Novato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767328/
https://www.ncbi.nlm.nih.gov/pubmed/36538565
http://dx.doi.org/10.1371/journal.pone.0279298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767328/
https://www.ncbi.nlm.nih.gov/pubmed/36538565
http://dx.doi.org/10.1371/journal.pone.0279298

Ejemplares similares